U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
RINTATOLIMOD
DASH   INN   MI   USAN   WHO-DD  
USAN   INN  
Official Name English
5'-INOSINIC ACID, HOMOPOLYMER, COMPLEX WITH 5'-CYTIDYLIC ACID POLYMER WITH 5'-URIDYLIC ACID (1:1)
Common Name English
RINTATOLIMOD [USAN]
Common Name English
POLY(5')-INOSINYL-(3'->) DUPLEX WITH POLY(DODECAKIS(3')-CYTIDYLYL-(5'->)3')-URIDYLYL-(5'->)
Common Name English
RINTATOLIMOD [MI]
Common Name English
POLY I: POLY C12U
Common Name English
ATVOGEN
Brand Name English
AMPLIGEN
Brand Name English
Rintatolimod [WHO-DD]
Common Name English
POLY I : POLY C12U
Common Name English
5'-INOSINIC ACID, HOMOPOLYMER, COMPLEX WITH (5'-CYTIDYLIC ACID POLYMER WITH 5'-URIDYLIC ACID 12:1) (1:1)
Common Name English
POLY(INOSINIC ACID):POLY(CYTIDYLIC ACID)(SUB 12)(URIDYLIC ACID)
Common Name English
5'-INOSINIC ACID HOMOPOLYMER COMPLEX WITH 5'-CYTIDYLIC ACID POLYMER WITH 5'-URIDYLIC ACID (1:1)
Common Name English
rintatolimod [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C2139
Created by admin on Sat Dec 16 13:11:41 GMT 2023 , Edited by admin on Sat Dec 16 13:11:41 GMT 2023
FDA ORPHAN DRUG 76893
Created by admin on Sat Dec 16 13:11:41 GMT 2023 , Edited by admin on Sat Dec 16 13:11:41 GMT 2023
FDA ORPHAN DRUG 57091
Created by admin on Sat Dec 16 13:11:41 GMT 2023 , Edited by admin on Sat Dec 16 13:11:41 GMT 2023
FDA ORPHAN DRUG 75993
Created by admin on Sat Dec 16 13:11:41 GMT 2023 , Edited by admin on Sat Dec 16 13:11:41 GMT 2023
FDA ORPHAN DRUG 907922
Created by admin on Sat Dec 16 13:11:41 GMT 2023 , Edited by admin on Sat Dec 16 13:11:41 GMT 2023
EU-Orphan Drug EU/3/15/1480
Created by admin on Sat Dec 16 13:11:41 GMT 2023 , Edited by admin on Sat Dec 16 13:11:41 GMT 2023
FDA ORPHAN DRUG 785520
Created by admin on Sat Dec 16 13:11:41 GMT 2023 , Edited by admin on Sat Dec 16 13:11:41 GMT 2023
Code System Code Type Description
EVMPD
SUB126941
Created by admin on Sat Dec 16 13:11:41 GMT 2023 , Edited by admin on Sat Dec 16 13:11:41 GMT 2023
PRIMARY
INN
9194
Created by admin on Sat Dec 16 13:11:41 GMT 2023 , Edited by admin on Sat Dec 16 13:11:41 GMT 2023
PRIMARY
FDA UNII
94325AJ25N
Created by admin on Sat Dec 16 13:11:41 GMT 2023 , Edited by admin on Sat Dec 16 13:11:41 GMT 2023
PRIMARY
EPA CompTox
DTXSID50191952
Created by admin on Sat Dec 16 13:11:41 GMT 2023 , Edited by admin on Sat Dec 16 13:11:41 GMT 2023
PRIMARY
CAS
38640-92-5
Created by admin on Sat Dec 16 13:11:41 GMT 2023 , Edited by admin on Sat Dec 16 13:11:41 GMT 2023
PRIMARY
ChEMBL
CHEMBL2107862
Created by admin on Sat Dec 16 13:11:41 GMT 2023 , Edited by admin on Sat Dec 16 13:11:41 GMT 2023
PRIMARY
NCI_THESAURUS
C1001
Created by admin on Sat Dec 16 13:11:41 GMT 2023 , Edited by admin on Sat Dec 16 13:11:41 GMT 2023
PRIMARY
MERCK INDEX
m9627
Created by admin on Sat Dec 16 13:11:41 GMT 2023 , Edited by admin on Sat Dec 16 13:11:41 GMT 2023
PRIMARY Merck Index
WIKIPEDIA
RINTATOLIMOD
Created by admin on Sat Dec 16 13:11:41 GMT 2023 , Edited by admin on Sat Dec 16 13:11:41 GMT 2023
PRIMARY
USAN
UU-167
Created by admin on Sat Dec 16 13:11:41 GMT 2023 , Edited by admin on Sat Dec 16 13:11:41 GMT 2023
PRIMARY
All of the following components must be present:
5'-URIDYLIC ACID 5'-CYTIDYLIC ACID COPOLYMER (1:12)
POLYINOSINIC ACID
ACTIVE MOIETY
RINTATOLIMOD
Definition References
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966